170 related articles for article (PubMed ID: 15710575)
1. Home-treatment of deep vein thrombosis in patients with cancer.
Ageno W; Grimwood R; Limbiati S; Dentali F; Steidl L; Wells PS
Haematologica; 2005 Feb; 90(2):220-4. PubMed ID: 15710575
[TBL] [Abstract][Full Text] [Related]
2. Selecting patients for home treatment of deep vein thrombosis: the problem of cancer.
Ageno W; Steidl L; Marchesi C; Dentali F; Mera V; Squizzato A; Crowther MA; Venco A
Haematologica; 2002 Mar; 87(3):286-91. PubMed ID: 11869941
[TBL] [Abstract][Full Text] [Related]
3. Home treatment of deep vein thrombosis: a two-years experience of a single institution.
Grau E; Real E; Pastor E; Viciano V; Aguiló J
Haematologica; 1998 May; 83(5):438-41. PubMed ID: 9658729
[TBL] [Abstract][Full Text] [Related]
4. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism.
Grau E; Tenias JM; Real E; Medrano J; Ferrer R; Pastor E; Selfa S
Am J Hematol; 2001 May; 67(1):10-4. PubMed ID: 11279651
[TBL] [Abstract][Full Text] [Related]
5. Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients.
Siragusa S; Arcara C; Malato A; Anastasio R; Valerio MR; Fulfaro F; Lo Coco L; Grimaudo S; Bajardi G; Abbadessa V; Gebbia N
Ann Oncol; 2005 May; 16 Suppl 4():iv136-139. PubMed ID: 15923414
[TBL] [Abstract][Full Text] [Related]
6. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression.
Labas P; Ohrádka B; Vladimír J; Cambal M
Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727
[TBL] [Abstract][Full Text] [Related]
7. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study.
Parisi R; Visonà A; Camporese G; Verlato F; Lessiani G; Antignani PL; Palareti G
Int Angiol; 2009 Feb; 28(1):68-72. PubMed ID: 19190559
[TBL] [Abstract][Full Text] [Related]
8. Eligibility for home treatment of deep vein thrombosis: a prospective study in 202 consecutive patients.
Schwarz T; Schmidt B; Beyer J; Schröder HE; Schellong SM
J Vasc Surg; 2001 Dec; 34(6):1065-70. PubMed ID: 11743562
[TBL] [Abstract][Full Text] [Related]
9. [Short-term and long-term evolution of deep vein thrombosis treated by a health care unit].
Martín-Carbonero L; Salgado X; Pedrajas JM; Armengol JG; Jiménez Rodríguez-Madridejos R; Fernández-Cruz A
Rev Clin Esp; 2002 Aug; 202(8):430-4. PubMed ID: 12199992
[TBL] [Abstract][Full Text] [Related]
10. Deep venous thrombosis in children and adolescents.
Levy ML; Granville RC; Hart D; Meltzer H
J Neurosurg; 2004 Aug; 101(1 Suppl):32-7. PubMed ID: 16206969
[TBL] [Abstract][Full Text] [Related]
11. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
12. Cost savings and effectiveness of outpatient treatment with low molecular weight heparin of deep vein thrombosis in a community hospital.
Lee M; Pao D; Hsu T; Sonderskov A
Can J Clin Pharmacol; 2004; 11(1):e17-27. PubMed ID: 15226523
[TBL] [Abstract][Full Text] [Related]
13. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].
Heidenreich C; Hohmann V; Bramlage P
Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593
[TBL] [Abstract][Full Text] [Related]
14. Management of thromboembolism in patients with cancer.
Viale PH
Oncol Nurs Forum; 1999; 26(10):1625-32; quiz 1633-4. PubMed ID: 10573679
[TBL] [Abstract][Full Text] [Related]
15. Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity.
Savage KJ; Wells PS; Schulz V; Goudie D; Morrow B; Cruickshank M; Kovacs MJ
Thromb Haemost; 1999 Sep; 82(3):1008-10. PubMed ID: 10494754
[TBL] [Abstract][Full Text] [Related]
16. Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis.
Naz R; Naz S; Mehboob M; Khalid GH
J Coll Physicians Surg Pak; 2005 Oct; 15(10):601-4. PubMed ID: 19810295
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis.
Schutgens RE; Beckers MM; Haas FJ; Biesma DH
Haematologica; 2005 Feb; 90(2):214-9. PubMed ID: 15710574
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients.
Kolomansky A; Hoffman R; Sarig G; Brenner B; Haim N
Isr Med Assoc J; 2006 Dec; 8(12):848-52. PubMed ID: 17214102
[TBL] [Abstract][Full Text] [Related]
19. The clinical course of deep vein thrombosis in patients with gynecologic cancer.
Morgan MA; Iyengar TD; Napiorkowski BE; Rubin SC; Mikuta JJ
Gynecol Oncol; 2002 Jan; 84(1):67-71. PubMed ID: 11748979
[TBL] [Abstract][Full Text] [Related]
20. Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry.
Bruscas MJ; Nieto JA; Perez-Pinar M; López-Jiménez L; Fernández-Capitán C; López-Chuliá F; Orue-Lecue MT;
Ann Hematol; 2007 Jul; 86(7):519-26. PubMed ID: 17437112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
